Effective Fip
Therapy for Cats
with FipDr
Advanced antiviral support designed to help manage FIPV replication in cats using GS-441524-based protocols. Trusted by veterinary communities worldwide.
HPLC Lab Batch Verified >99.8% Purity
Unlike unverified FIP products with inconsistent active concentrations, FipDr™ coordinates rigorous batch analysis for every production cycle. Each vial contains active, pharmaceutical-grade GS-441524 formulated under sterile regulations.
GS-441524 Dosage Calculator
Instantly calculate your cat's recommended daily dosage based on weight and diagnostic category. Always consult a veterinarian for final verification.
FIP Symptom Evaluator
Check symptoms your cat is showing to see if they align with wet, dry, neurological, or ocular FIP types.
The 84-Day Recovery Journey
FIP cure is achievable by committing to a 12-week daily GS-441524 regimen.
Days 1 - 14
Initial StabilizationDaily injections quickly shut down viral replication. Cats typically show dramatic recovery in activity, appetite, and temperature in 48-72 hours.
Days 15 - 42
Toxicity ClearanceOrgans and blood values start normalizing. Weight monitoring is critical—adjust GS dosage weekly as the cat regains mass.
Days 43 - 84
Viral EradicationTransition to oral capsules (optional) for stress-free final weeks. Eradicates virus in tissues before ending treatment and entering observation.
Give Your Cat a Second Chance at Life
Feline Infectious Peritonitis was historically fatal. Today, FipDr™ has supported thousands of owners through the 84-day treatment journey, resulting in a documented recovery rate over 92%. Start the recovery protocol today.
Shop FIP Medications
Select verified purity GS-441524 injectables and oral capsules.
FipDr™ GS-441524 Injectable 20mg/ml (7ml)
Standard concentration FIP injectable treatment. Purity level >99.8%. Recommended for Wet and Dry FIP cases.
FipDr™ GS-441524 Injectable 30mg/ml (8ml)
High concentration FIP injectable treatment. Ideal for neurological, ocular, or heavy cats to reduce injection volume.